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Leptospirosis is a worldwide zoonotic and neglected infectious disease of human
and veterinary concern, caused by pathogenic Leptospira species. Although bleeding
is a common symptom of severe leptospirosis, the cause of hemorrhage is
not completely understood. In severe infections, modulation of hemostasis by
pathogens is an important virulence mechanism, and hemostatic impairments such
as coagulation/fibrinolysis dysfunction are frequently observed. Here, we analyze the
coagulation status of experimentally infected hamsters in an attempt to determine
coagulation interferences and the origin of leptospirosis hemorrhagic symptomatology.
Hamsters were experimentally infected with L. interrogans. The lungs, kidneys, and
livers were collected for culture, histopathology, and coagulation assays. L. interrogans
infection disturbs normal coagulation in the organs of animals. Our results suggest
the presence of a thrombin-like factor or FX activator, which is able to activate FII
in the leptospirosis organ extracts. The activity of those factors is accelerated in the
prothrombinase complex. Additionally, we show for the first time that live leptospires
act as a surface for the prothrombinase complex assembly. Our results contribute to
the understanding of leptospirosis pathophysiological mechanisms and may open new
routes for the discovery of novel treatments in the severe manifestations of the disease.
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INTRODUCTION
Leptospirosis is a neglected zoonotic bacterial disease of worldwide public health importance. It
affects humans, domestic, and wildlife animals and it is caused by pathogenic bacteria of the genus
Leptospira (Levett, 2001; Bharti et al., 2003). Human infection occurs mainly through contact
with tissues or urine of wild or domestic infected animals or exposure to contaminated soil or
water (Faine et al., 1999; Plank and Dean, 2000). Although underestimated, it is believed that
more than 500,000 cases of symptomatic leptospirosis cases occur annually (Ko et al., 2009).
Human leptospirosis incidence is low in developed countries, whereas in developing countries, the
high incidence is associated to the lack of adequate sanitation as well as favorable environmental
conditions to the transmission of leptospires (Haake et al., 2002; Hartskeerl et al., 2011).
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Leptospires typically enter the body through the mucous
membranes or through cuts on the skin, persist and multiply in
the bloodstream during the leptospiremic phase of the illness,
spreading into the surrounding tissue. Kidneys and liver are
the preferential colonization sites. Soon after the host has
developed an immunological response, bacteria are cleared from
blood, characterizing the immune phase (Levett, 2001). Human
infection varies from subclinical to severe manifestations, but
usually presents initially as a non-specific, sudden onset illness
with fever, myalgia, and headache. Signs of bleeding are also
common, and occur in most patients with severe leptospirosis
(Levett, 2001; Vinetz, 2001).
Hemostasis is a tightly regulated biological process that stops
blood loss when a vascular injury occurs. Primary hemostasis
involves the response of the vascular endothelium and platelets
to blood vessel injury, resulting in the formation of a platelet
plug. Secondary hemostasis reinforces the platelet plug by the
deposition of insoluble fibrin, formed by the action of the
thrombin generated during the proteolytic coagulation cascade.
Thus, the conversion of prothrombin to thrombin is crucial for
hemostasis. The specific proteolytic activation of prothrombin
is catalyzed by the prothrombinase complex, which results
from the reversible binding of the coagulation factor Xa (FXa)
to the factor Va (FVa) in phospholipidic membranes in the
presence of calcium ions. The clots formed to help to stop
the bleeding are eventually dissolved through fibrinolysis. There
is a delicate equilibrium between coagulation and fibrinolysis
during the hemostatic process, thus any disturbance may lead to
coagulopathies resulting in thrombosis or hemorrhage.
Bleeding is a common symptom of severe leptospirosis.
Although the cause of leptospirosis hemorrhages is not
completely understood, some studies report ongoing fibrinolysis,
activation of coagulation, impaired anticoagulation, and
thrombocytopenia, whereas the involvement of disseminated
intravascular coagulation is controversial (Sitprija et al., 1980;
Edwards et al., 1986; De Francesco Daher et al., 2002; Chierakul
et al., 2008; Wagenaar et al., 2010; Vieira et al., 2016; Vieira and
Nascimento, 2016). Endothelial cell infection and activation has
also been implied as a mechanism in leptospirosis hemorrhages,
contributing to severe disease manifestations (Martinez-Lopez
et al., 2010; Goeijenbier et al., 2015). Asmodulation of hemostasis
by pathogenic bacteria is an important virulence mechanism
(Tapper and Herwald, 2000; Frick et al., 2007; Oehmcke
and Herwald, 2010), we believe that coagulation/fibrinolysis
dysfunction might be involved in the pathophysiological
manifestation of leptospirosis. The present investigation aims
to further decipher the role of coagulation and hemostatic
imbalance during the disease in vivo, using leptospirosis hamster
model.
Here, we show that L. interrogans infection disturbs normal
coagulation in the organs of animals, observable by the
prolongation of global coagulation tests. Also, our results suggest
the presence of a thrombin-like factor or FXa activator able to
activate FII in the leptospirosis organ extracts, which activity
is accelerated in the prothrombinase complex. Furthermore, we
show that live leptospires act as a surface for the prothrombinase
complex assembly. Our results contribute to understanding of
coagulation disorders during leptospirosis and may shed light to
novel strategies to fight the disease.
METHODS
Bacteria Strains and Culture Conditions
L. interrogans serovar Kennewicki strain Pomona Fromm (LPF)
were cultured at 28◦C in Elinghausen-McCullough-Johnson-
Harris (EMJH) medium (BD, Difco) supplemented with 10%
Leptospira enrichment EMJH medium (BD, Difco), 0.3 g/L
peptone (BD, Difco), and 0.2 g/L meat extract (Sigma-Aldrich).
Animal Experimental Infection
Groups of 4–6 male Golden Syrian hamsters (8–10 weeks old)
were experimentally infected intraperitoneally with the lethal
dose of 104 L. interrogans serovar Kennewicki strain Pomona
Fromm (LPF)/animal in 200 µL PBS (Phosphate Buffer Saline).
After 0, 3, 6, 8, 9, or 10 days post-infection (pi.), the animals were
euthanized and the lungs, kidneys, and livers were aseptically
collected. A control group of non-infected (ni) hamsters was
maintained in the same conditions for 10 days.
Organ-Derived Leptospira Culture
The organs were aseptically washed twice with PBS, macerated
in PBS and inoculated onto semi-solid EMJH medium. The
samples were maintained at 28◦C and the growth of leptospires
in the cultures was monitored for up to 40 days. The cultures
were considered positive by visual determination and dark-field
microscopy confirmation.
Organ Extracts Processing
After collection, the lungs, kidneys and livers were immediately
washed twice with PBS. Organ fragments were added to 10
µL/mg lysis buffer (150 mM sodium chloride, 1% Triton X-100,
0.1% sodium-dodecyl sulfate, 50 mM Tris-HCl pH 7.4). After
maceration by pestle and mortar, the samples were centrifuged
to debris removal. The protein contents of the extracts were
determined by Bradford assay.
Histopathological Analysis
Representative tissue samples were collected from the kidneys,
liver, and lungs of the animals. Tissue sections were fixed in
10% neutral formalin and routinely embedded in paraffin. Tissue
sections (2–4 µm) were stained with haematoxylin-eosin (H-E)
and examined by an experienced pathologist.
Clotting Assays
Prothrombin time (PT), thrombin clotting time (TCT), and
activated partial thromboplastin time (aPTT) were measured by
standard procedures (Knights and Ingram, 1967). The results
were expressed in seconds and the maximum time of the test
was 300 s. The tests were made in duplicate and the results were
expressed as averages of each sample determination.
Prothrombin F1+2 Fragments Assay
The F1+2 fragments contents of the organ extracts were
determined by using the kit Enzygnost F1+2 (Dade Behring)
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according to the manufacturer instructions. Twenty microliters
of the samples at 2 mg/mL were used for each replicate.
Preparation of the Phospholipidic
Membranes
The phosphatidylserine/phosphatidylcholine (PSPC; Sigma)
membranes were prepared as described elsewhere (Barenholz
et al., 1977).
Prothrombinase Complex Assay
The complex was formed bymixing 8 nMFXa (Hyphen Biomed),
5 nM FVa (Sigma), 10 nM CaCl2, and 3 µM PCPS (75:25
mol/mol) in buffer containing 0.05 M Tris/HCl, 150 mM NaCl,
pH 7.4. The mixture was incubated for 30 min at 37◦C with or
without the addition of the organ extracts (100 ng/µL), followed
by addition of 20 nM prothrombin (FII; Hyphen Biomed) and
1 mM of the thrombin-specific chromogenic substrate S-2238
(Hyphen Biomed). The formation of thrombin was determined
absorbance determination at 405 nm at different time points. In
the blank reaction, FII was omitted.
Alternatively, experiments were performed without the
addition of FXa or FII. We also analyzed the formation of
the complex by substituting the PCPS by live leptospires (5 ×
107/mL).
FXa and Thrombin Activity Assays
Leptospires (108, 5 × 107, and 107/mL) were lysed by gentle
sonication in buffer containing 0.05 M Tris/HCl, 10 nM CaCl2,
150 mM NaCl, pH 7.4. After addition of 1 mM chromogenic
substrate S-2238 or S-2765 (Hyphen Biomed) for thrombin and
FXa activities, respectively, the extracts were incubated for 16 h at
37◦C and the optical densities (ODs) were measured at 405 nm.
Ethics Statement
All animal studies were approved by the Ethical Committee
for Animal Research of Instituto Butantan and of School of
Veterinary Medicine and Animal Science, University of Sao
Paulo, Sao Paulo, SP, Brazil under the protocols 798/11 and
3158/13, respectively. The Committees in Animal Research
adopt the guidelines of the Brazilian College of Animal
Experimentation.
RESULTS
Hamster Infection
Groups of hamsters were experimentally infected
intraperitoneally with a lethal dose of L. interrogans. After 0, 3,
6, 8, 9, or 10 days, the animals were euthanized and the lungs,
kidneys and livers were collected for culture, histopathology,
and coagulation assays. Although not initially planned, the
group euthanized at day 9 was included because the animals
were severely sick and would not survive until the day 10. A
group of non-infected hamsters was maintained throughout the
experiment and exhibited no signs of disease.
In the infected hamsters, there was a rapid migration of
Leptospira to the liver, as all animals presented positive culture
as early as day 3 pi. In the kidneys and lungs, the bacterial
load progressively increased, peaking on days 6–8 pi. After that,
we noted a gradual clearance of the leptospires from lungs and
livers, whereas there seems to be a bacterial persistence in kidneys
(Table 1).
The histopathological analysis of organs from the infected
group showed significant and progressive lesions accompanying
the evolution of the disease, while groups at day 0 pi. and non-
infected showed only discrete congestion. The observed lesions
are characteristic of leptospirosis, and are described in Table 2.
Noteworthy, intense congestion and hemorrhage were observed
in lungs, while nephrosis and necrosis were observed in the
kidneys of the severely sick animals. The livers showed the
typical loss of normal trabecular architecture pattern observed in
leptospirosis (Figure 1).
Coagulation Times
In an attempt to better determine the origin of the leptospirosis
hemorrhages, we prepared extracts of the lungs, kidneys, and
livers of infected animals and control group. The extracts were
assayed for their ability to interfere with the normal clotting
of human plasma. The extracts of all organs prolonged the PT,
denoting an interference with the extrinsic coagulation cascade,
as well as the aPTT, interfering with the intrinsic or common
pathways (Figures 2A,B). The TCT was also prolonged, showing
that the final steps of coagulation were also compromised
(Figure 2C). A stronger interference was observed with lung and
liver extracts in all the assays when compared to extracts from
kidneys. The ability to prolong the clotting times was dependent
on the evolution of the disease. In some assays, the coagulation
interference of samples from animals at day 10 pi. was lower than
the day 9 pi. This can be explained by the fact that the animals
euthanized at day 9 pi. were severely sick and would not survive
until the day 10, thus the euthanasia was anticipated. To further
assess the coagulation activation, we measured prothrombin
F1+2 fragments within the organ samples. The F1+2 fragments
contents were higher during the progression of the disease, being
the peak observed at days 6 and 8 pi. (Figure 2D). The results are
in line with the coagulation times experiments, corroborating the
coagulation activation observation.
TABLE 1 | Presence of viable Leptospira in the organs of experimentally
infected hamsters.
Days post-infection Lungs Kidneys Livers
0 0/6 0/6 0/6
3 2/6 3/6 6/6
6 5/6 5/6 5/6
8 3/6 5/6 3/6
9 3/4 3/4 3/4
10 0/5 3/5 1/5
10 (ni) 0/6 0/6 0/6
The animals were infected with a lethal dose of L. interrogans serovar Kennewicki strain
Pomona Fromm (LPF). After 0, 3, 6, 8, 9, or 10 days post-infection, the animals were
euthanized and the lungs, kidneys, and livers were aseptically collected. A control group
of non-infected (ni) hamsters was maintained in the same conditions for 10 days. The
organs were processed and inoculated into semi-solid EMJH medium. The growth of
leptospires in the cultures were monitored for up to 40 days.
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TABLE 2 | Histopathological analysis of organs from hamsters experimentally infected with Leptospira.
Organ Days post-infection Histopathological observation
Lung 0 Discrete congestion
3 Congestion, discrete widened alveolar septa
6 Congestion, discrete hemorrhage, widened alveolar septa, proliferation of bronchial epithelium
8 Congestion, multiple foci of widened alveolar septa, hemorrhage
9 Discrete congestion, diffuse widened alveolar septa (interstitial pneumonia), proliferation of bronchial epithelium
10 Congestion, intense hemorrhage, interstitial pneumonia, hyperplasia, hypertrophy of bronchial epithelium
10 (ni) Discrete congestion
Kidney 0 Discrete congestion
3 Discrete congestion
6 Congestion, discrete hemorrhage
8 Congestion, hemorrhage, foci of nephrosis, and tubular necrosis
9 Intense congestion, intense hemorrhage, nephrosis, and tubular necrosis
10 Intense congestion, intense hemorrhage, intense tubular necrosis
10 (ni) Discrete congestion
Liver 0 Discrete congestion
3 Discrete focal and periportal hepatitis
6 Congestion, discrete hemorrhage, cytoplasmic rarefaction in hepatocytes
8 Congestion, foci of hepatitis, vacuolar degeneration, degradation of trabecular architecture, discrete hepatocyte necrosis
9 Congestion, hemorrhage, degradation of trabecular architecture, focal hepatitis
10 Congestion, focal and periportal hepatitis, hepatocyte cytoplasmic rarefaction
10 (ni) Discrete congestion
The animals were infected with a lethal dose of L. interrogans serovar Kennewicki strain Pomona Fromm (LPF). After 0, 3, 6, 8, 9, or 10 days post-infection, the animals were euthanized
and the lungs, kidneys, and livers were removed and prepared for histopathology by H-E staining. Organs from non-infected (ni) hamsters were used as controls.
Prothrombinase Complex
Prothrombinase complex is comprised of FXa, FVa, and FII
assembled on a phospholipid surface in the presence of Ca2+.
Prothrombinase is the cornerstone of the coagulation cascade;
the complex is positioned in such amanner that both the intrinsic
and extrinsic pathways support its function and production,
culminating in the production of thrombin. As our previous
results showed that the organ extracts of infected hamsters
prolonged both PT, aPTT, and TCT, we decided to evaluate
if any interference could occur in the formation and activity
of the complex. We chose to evaluate animals in day 8 pi.
in comparison to non-infected ones. As shown in Figure 3,
when extracts of the lungs and kidneys from animals in
day 8 were added to the prothrombinase complex mixture,
acceleration in the formation of the complex occurred. An
effect was also observed with the lungs from ni. animals,
although significantly lower than from day 8. No interference
was observed when liver samples (day 8 or ni.) or kidneys from
ni. animals were added to prothrombinase complex mixture
when compared to the control (prothrombinase complex with no
additions).
Coagulation Factors Activities
In the next experiments, we assayed the ability of organ extracts
from infected animals to activate FII. When lungs from ni. and
lungs and kidneys from infected hamsters day 8 were mixed
with FII, the formation of thrombin, measured by the substrate
hydrolysis, was observed to similar ODs of the ones obtained
in the prothrombinase complex assay (shown in Figure 3) only
after 16 h incubation (Figure 4). We hence conclude that the
organs from L. interrogans infected animals contain a factor able
to activate FII, which activity is accelerated in the prothrombinase
complex. Therefore, we performed the prothrombinase complex
assay omitting FXa from the mixture, to evaluate if any FXa-like
could be responsible for the FII activation or a thrombin-like
responsible for substrate hydrolysis. A minor FXa- or thrombin-
like activity was observed. The substrate hydrolysis ODs similar
the ones obtained in the full prothrombinase complex assay
(shown in Figure 3), were obtained only after 16 h incubation
(Figure 5), denoting a slow activation of the prothrombinase
complex.
To evaluate the origin of the FXa- or thrombin-like
activities observed (whether from the host or bacteria), we
assayed both organ extracts from infected animals and L.
interrogans extracts for FXa and thrombin activities by specific
chromogenic substrates. The organs from infected hamsters
(livers, kidneys, and lungs) resulted in low FXa (Figure 6A)
and thrombin activities (Figure 6B) even after 16 h incubation,
while the bacterial extracts occasioned dose-dependent and
significant FXa (Figure 7A) and thrombin activities (Figure 7B).
We conclude by these experiments that leptospires were
responsible for FXa and thrombin-like coagulation factors
activities that were detected in the previous assay (see
Figure 5).
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FIGURE 1 | Representative photomicrographs from histopathological findings in organs from hamsters experimentally infected with Leptospira. (A)
Hamster liver 8 days after inoculation with L. interrogans: observe the disorganization and loss of normal trabecular architecture; (B) control liver; (C) hamster kidney 8
days after inoculation with L. interrogans: observe tubular nephrosis and necrosis, with the presence of hyaline casts; (D) control kidney; (E) hamster lung 8 days after
inoculation with L. interrogans: observe the intense congestion and hemorrhage; (F) control lung. H&E. Bar = 50 µm.
FIGURE 2 | Leptospirosis organ extracts prolong coagulation times and contain higher levels of prothrombin F1+2 fragments. Lungs, kidneys, and livers
of experimentally infected hamsters were removed after 0, 3, 6, 8, 9, or 10 days pi. Organs from a non-infected group (10 ni) were used as controls. The organs
extracts were mixed with human citrated plasma and the PT (A), aPTT (B), and TCT (C) were determined in a coagulometer. Plasma alone was used as control in
those experiments. (D) Depicts the quantification of prothrombin F1+2 fragments in the organ extracts. The bars represent the mean of the ratio samples/control
plasma ± standard deviation of triplicates. #Ratio sample/control plasma > 3.
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FIGURE 3 | Interference of leptospirosis organ extracts on the activity of prothrombinase complex. Lungs, kidneys, and livers extracts of
Leptospira-infected hamsters at day 8 or non-infected (ni.) animals were mixed with FXa, FVa, and PCPS in buffer containing calcium. After 30 min incubation at
37◦C, FII was added and its conversion to thrombin was measured as cleavage of the chromogenic substrate (OD = 405 nm) at different time points (A). In (B), the
bars represent the absorbance obtained 30 min after FII addition. The values represent the mean ± standard deviation of triplicates and are representative of two
independent experiments.
FIGURE 4 | Activity of leptospirosis organ extracts on the conversion
of FII to thrombin. Lungs, kidneys, and livers extracts of Leptospira-infected
hamsters at day 8 or non-infected (ni.) animals were mixed with FII and
incubated at 37◦C for 16 h. The generation of thrombin was determined as the
cleavage of the specific chromogenic substrate. Controls containing active
thrombin alone, FII alone, or lacking FII (blank) were used. The values represent
the mean ± standard deviation of triplicates and are representative of two
independent experiments.
The Assembly of the Prothrombinase
Complex May Occur at the Leptospiral
Surface
We have previously shown that leptospires can function
as a surface for the contact system activation, binding to
coagulation factors (Vieira et al., 2016). When we performed the
prothrombinase complex assay by substituting the PSPC
by live leptospires, a strong activation of the complex
was observed (Figures 8A,B—control), showing that the
leptospires membrane could play a similar role and act as
a phospholipidic surface for the prothrombinase complex
assembly. For comparison purposes, we performed the
prothrombinase complex in the presence of PSPC (positive
FIGURE 5 | Ability of leptospirosis organ extracts on the activation of
FX and formation of the prothrombinase complex. Lungs, kidneys, and
livers extracts of Leptospira-infected hamsters at day 8 or non-infected (ni.)
animals were mixed with FVa and PCPS in buffer containing calcium. FXa was
omitted from the mixture. A positive control containing FXa was used. In
addition, a control lacking FXa as well as a blank reaction lacking FII were also
employed. After 30 min incubation at 37◦C, FII was added and its conversion
to thrombin was measured as cleavage of the chromogenic substrate (OD =
405 nm) after 16 h. The values represent the mean ± standard deviation of
triplicates and are representative of two independent experiments.
control). Additionally, when the organ extracts were added to
the prothrombinase complex mixture using leptospires as a
surface for assembly, we observed the acceleration of the reaction
(Figure 8A), similar as observed when PSPC was used (see
Figure 3).
Hypothesis of Leptospiral Interference with
the Host Hemostasis
Figure 9 depicts the binding and activation of the
prothrombinase complex at the leptospiral surface. In the
presence of calcium ions, the cofactor FVa binds to the
leptospiral outer membrane surface, recruiting the coagulation
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FIGURE 6 | Activity of leptospirosis organ extracts on the cleavage of FXa and thrombin-specific substrates. Lungs, kidneys, and livers extracts of
Leptospira-infected hamsters at day 8 or non-infected (ni.) animals were mixed with the substrates S-2765 (A) or S-2238 (B) in buffer containing calcium for thrombin
and FXa activity, respectively. Controls containing FXa and thrombin were used. After 16 h incubation at 37◦C, the cleavage of the chromogenic substrates was
measured. The values represent the mean ± standard deviation of triplicates and are representative of two independent experiments.
FIGURE 7 | Activity of L. interrogans on the cleavage of FXa and thrombin-specific substrates. L. interrogans extracts (representing final concentration of
108, 5 × 107 or 107 cells/mL) were mixed with the substrates S-2765 (A) or S-2238 (B) in buffer containing calcium for thrombin and FXa activity, respectively.
Controls lacking leptospires were used (blank). After 16 h incubation at 37◦C, the cleavage of the chromogenic substrates was measured. The values represent the
mean ± standard deviation of triplicates and are representative of two independent experiments.
FIGURE 8 | L. interrogans cells role as phospholipidic surface for the assembly of the prothrombinase complex. Lung, kidney, and liver extracts of
Leptospira-infected hamsters at day 8 or non-infected (ni.) animals were mixed with FXa, FVa, and leptospires as source of phospholipidic surface in buffer containing
calcium. A positive control lacking leptospires and containing PSPC was used. After 30 min incubation at 37◦C, FII was added and its conversion to thrombin was
measured as cleavage of the chromogenic substrate (OD = 405 nm) at different time points (A). In (B), the bars represent the absorbance obtained 30 min after FII
addition. The values represent the mean ± standard deviation of triplicates and are representative of two independent experiments.
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FIGURE 9 | Prothrombinase complex assembly at the leptospiral surface. In the presence of calcium ions, FVa binds to the leptospiral surface, acting as a
receptor for FII and FXa. Within the prothrombinase complex, thrombin formation is augmented. Both the intrinsic and extrinsic pathways of coagulation lead to FX
activation. The cofactor FV can be activated by FXa, thrombin, and plasmin.
factors FII (prothrombin), and FXa. Although thrombin can be
generated in solution via activation by FXa in the presence of
calcium ions, the thrombin formation is accelerated more than
300,000 times within the prothrombinase complex assembled at
a phospholipidic surface (Rosing et al., 1980; Betz et al., 1997).
FX can be activated by either the intrinsic (contact system) and
extrinsic (tissue factor) pathways of coagulation. FXa, thrombin,
and plasmin may act as a source for FV activation.
DISCUSSION
Bleeding is a common symptom of severe leptospirosis.
Pathological findings reveal widespread hemorrhages at mucous
membranes, peritoneum, muscles, and organs such as kidneys
and lungs (Arean, 1962; De Brito et al., 2013). The intense intra-
alveolar hemorrhage with interstitial inflammatory infiltrates
and vascular extravasation seems to be unique for leptospirosis
(Pereira et al., 2005; De Brito et al., 2013). However, the cause
and mechanisms of bleeding are still not clearly elucidated.
Accumulating data indicate that compromised hemostasis might
be involved in the manifestation of leptospirosis hemorrhagic
syndromes. Evidence point toward activation of coagulation,
impaired anticoagulation, and activation of fibrinolysis (Sitprija
et al., 1980; Edwards et al., 1986; De Francesco Daher et al., 2002;
Chierakul et al., 2008; Wagenaar et al., 2010; Vieira et al., 2013).
We have previously shown that both human intrinsic and
extrinsic pathways of coagulation are modulated in response
to Leptospira or leptospiral secreted proteins, promoting host
pro-coagulant, and pro-inflammatory state, especially in the
early phase of the disease (Vieira et al., 2016). We revealed
the important role of tissue factor and tissue factor-bearing
microvesicles in the induction of the systemic pro-coagulant
state during leptospirosis. We have also described the interaction
of Leptospira with the fibrinolytic system by capturing human
plasminogen on its surface and stimulating an imbalance of the
normal fibrinolysis by enhancing the availability of plasminogen
activators and plasmin generation (Vieira et al., 2009, 2011, 2013;
Vieira and Nascimento, 2016).
In the present investigation, we analyzed the coagulation
status of experimentally infected hamsters’ organ extracts. We
aimed to detect coagulation interferences and the possible origin
of leptospirosis hemorrhagic symptomatology. We produced a
lethal infection that mimicked the clinical presentation of severe
leptospirosis in patients and animals (Hartman et al., 1986;
Faine, 1999; Yang et al., 2006; Abgueguen et al., 2008; Daher
et al., 2010). The focus of our study was on the liver, kidneys,
and lungs of experimentally infected hamsters, as they have the
highest bacterial burden in leptospirosis, and frequently present
hemorrhagic foci and organ failure in severe infection (Faine,
1999).
In the infected hamsters, there was a rapid migration of
Leptospira to the liver, and to a lesser extent to the kidneys and
lungs, in which the bacterial load progressively increased. After
that, we noted the gradual clearance of the leptospires from
the lungs and livers, while bacteria apparently persisted on the
kidneys, as previously reported (Ko et al., 2009; Coutinho et al.,
2014). The progression of the disease was associated with tissue
pathologies and marked alterations of liver, kidney, and lung
structures. All the organs exhibited hemorrhage foci from day 6
after infection.
The presence of the organ extracts prolonged the plasma
global coagulation tests (PT, aPTT, and TCT). These results can
be originated by inhibition of the intrinsic, extrinsic, and/or
common coagulation pathways, a consumption coagulopathy
or hyperfibrinolysis. The higher contents of prothrombin
F1+2 fragments in the infected animals’ organ samples
further suggest coagulation activation and ongoing coagulation
factors consumption. Prolonged clotting times were shown in
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human leptospirosis patients, and PT prolongation seems to
be associated with both clinical bleeding and poor outcome
(Chierakul et al., 2008; Wagenaar et al., 2010).
At the final steps of coagulation, FII can generate thrombin by
two pathways: (i) in the presence of FXa and calcium ions or (ii)
in the presence of FXa, FVa, and calcium ions in a phospholipidic
surface—the prothrombinase complex (Colman et al., 1994; Betz
and Krishnaswamy, 1998; Yang et al., 2008; Qureshi et al., 2009).
Formation of the full prothrombinase complex is supported by
both intrinsic and extrinsic pathways of coagulation, and may
enhance the conversion of FII to thrombin by 300,000-fold
(Rosing et al., 1980; Betz et al., 1997). We observed a noticeable
acceleration of the prothrombinase complex formation when
lungs and kidneys extracts of the infected hamsters were added.
The organ extracts were only slightly effective in the activation
of FII. This was also observable by the prothrombinase complex
activity when FXa was omitted, resulting in slow acceleration of
the complex. Altogether, our results suggest the presence of a
FXa-like factor capable of activating FII or a thrombin-like factor
competent in hydrolyzing the substrate in the leptospirosis organ
extracts. Additionally, the activity of those factors is accelerated
in the prothrombinase complex assembled on a phospholipidic
surface.
We reveal that the FXa- and thrombin-like activities
originated from the bacteria rather than from the organs.
This could be either by Leptospira endogenous molecules or
leptospiral capture of hosts factors. Indeed, we have previously
shown that leptospires bind a number of host coagulation factors
from the intrinsic and common pathways of coagulation (FXII,
FXa, thrombin; Fernandes et al., 2015; Vieira et al., 2016). The
assembling and activation of the contact system at the bacterial
surface leads to an activation of the up-stream coagulation
factors. Moreover, leptospires induce prolonged aPTT and PT in
human plasma in vitro by depletion of coagulation factors bound
to their surface (Vieira et al., 2016). Therefore, the observed
activities are probably due to Leptospira interaction with host
molecules.
The cofactor FV can be activated by FXa, thrombin, and
plasmin. Within the prothrombinase complex, FVa binds to the
negatively charged phospholipidic surfaces acting as a receptor
for FII and FXa. Here, we show that leptospires can act as
a surface for the prothrombinase complex assembly. To our
knowledge, this is the first time such bacterial ability is described.
Our previous results showed that binding of plasmin (Vieira
et al., 2009) and FXa (Vieira et al., 2016) to the leptospiral
surface denote various mechanisms by which these bacteria can
activate the coagulation cascade. By recruiting host molecules
such as plasmin, contact system factors and prothrombinase
complex factors to the bacterial surface, leptospires create a very
effective environment for the activation of host coagulation and
modulation of hemostasis.
Studies demonstrate that the coagulation system is strongly
activated in patients with leptospirosis (Wagenaar et al., 2010).
The induction of high levels of circulating pro-coagulant
microvesicles in the host can induce a systemic pro-coagulant
state (Vieira et al., 2016). Additionally, the assembly and
activation of the contact system and prothrombinase complex
at the leptospiral surface, as well as binding of plasmin,
can lead to local and systemic coagulation and fibrinolysis
activation (Vieira et al., 2009, 2013, 2016). Based on our
results presented here and the data available in the literature,
it is suggested that the leptospirosis hemorrhagic syndromes
are possibly caused by consumption coagulopathies and
hyperfibrinolysis.
Our results add new information regarding Leptospira
infection. However, we are aware of some limitations. Besides
being one of the most studied and used animal model for
leptospirosis (Haake, 2006), hamsters are not isogenic, so variable
individual responses are expected—and that is why we analyzed
pooled samples. Moreover, the leptospires dose we used to
inoculate the animals may not reflect the burden acquired
during natural infection. However, based on a survival curve
and LD50 calculation, we had to stipulate a lethal dose in
which all the animals would die within ∼10 days post infection.
Another drawback is the route of administration. Although the
intraperitoneal inoculation is not the natural infection route
for leptospires, it is the standard method employed for animal
challenge experiments (Haake, 2006; Coutinho et al., 2014).
In any event, we believe that our results further contribute
to the understanding of the leptospirosis pathophysiological
mechanisms, showing new mechanisms by which the pathogen
can interfere with the host hemostasis.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments: MV, SD. Performed the
experiments: MV, SD, ZM, MD. Analyzed the data: MV, SD, MD.
Contributed with reagents/materials/analysis tools: SV, MD, AN.
Wrote the paper: MV, AN.
ACKNOWLEDGMENTS
FAPESP (grants 12/23913-9 and 14/50981-0), CNPq (grants
302758/2013-5 and 441449/2014-0), and Fundação Butantan,
Brazil, financially supported this work. MV is a post-doctoral
scholarship holder from FAPESP (2012/50523-7). The funders
had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
REFERENCES
Abgueguen, P., Delbos, V., Blanvillain, J., Chennebault, J. M., Cottin, J.,
Fanello, S., et al. (2008). Clinical aspects and prognostic factors of
leptospirosis in adults. Retrospective study in France. J. Infect. 57, 171–178.
doi: 10.1016/j.jinf.2008.06.010
Arean, V. M. (1962). The pathologic anatomy and pathogenesis of fatal human
leptospirosis (Weil’s disease). Am. J. Pathol. 40, 393–423.
Barenholz, Y., Gibbes, D., Litman, B. J., Goll, J., Thompson, T. E., and
Carlson, R. D. (1977). A simple method for the preparation of homogeneous
phospholipid vesicles. Biochemistry 16, 2806–2810. doi: 10.1021/bi0063
1a035
Frontiers in Microbiology | www.frontiersin.org 9 March 2017 | Volume 8 | Article 500
Vieira et al. Coagulation Disorders during Experimental Leptospirosis
Betz, A., and Krishnaswamy, S. (1998). Regions remote from the site of cleavage
determine macromolecular substrate recognition by the prothrombinase
complex. J. Biol. Chem. 273, 10709–10718. doi: 10.1074/jbc.273.17.10709
Betz, A., Vlasuk, G. P., Bergum, P. W., and Krishnaswamy, S. (1997). Selective
inhibition of the prothrombinase complex: factor Va alters macromolecular
recognition of a tick anticoagulant peptide mutant by factor Xa. Biochemistry
36, 181–191. doi: 10.1021/bi962060g
Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A., Diaz, M. M., Lovett, M.
A., et al. (2003). Leptospirosis: a zoonotic disease of global importance. Lancet
Infect. Dis. 3, 757–771. doi: 10.1016/S1473-3099(03)00830-2
Chierakul,W., Tientadakul, P., Suputtamongkol, Y.,Wuthiekanun, V., Phimda, K.,
Limpaiboon, R., et al. (2008). Activation of the coagulation cascade in patients
with leptospirosis. Clin. Infect. Dis. 46, 254–260. doi: 10.1086/524664
Colman, R. W., Rao, A. K., and Rubin, R. N. (1994). Factor XI deficiency and
hemostasis. Am. J. Hematol. 45, 73–78. doi: 10.1002/ajh.2830450111
Coutinho, M. L., Matsunaga, J., Wang, L. C., de la Pena Moctezuma, A., Lewis,
M. S., Babbitt, J. T., et al. (2014). Kinetics of Leptospira interrogans infection in
hamsters after intradermal and subcutaneous challenge. PLoS Negl. Trop. Dis.
8:e3307. doi: 10.1371/journal.pntd.0003307
Daher, E. F., Lima, R. S., Silva Junior, G. B., Silva, E. C., Karbage, N. N., Kataoka,
R. S., et al. (2010). Clinical presentation of leptospirosis: a retrospective study
of 201 patients in a metropolitan city of Brazil. Braz. J. Infect. Dis. 14, 3–10.
doi: 10.1016/S1413-8670(10)70002-7
De Brito, T., Aiello, V. D., da Silva, L. F., Goncalves da Silva, A.M., Ferreira da Silva,
W. L., Castelli, J. B., et al. (2013). Human hemorrhagic pulmonary leptospirosis:
pathological findings and pathophysiological correlations. PLoS ONE 8:e71743.
doi: 10.1371/journal.pone.0071743
De Francesco Daher, E., Oliveira Neto, F. H., and Ramirez, S. M. (2002).
Evaluation of hemostasis disorders and anticardiolipin antibody in patients
with severe leptospirosis. Rev. Inst. Med. Trop. Sao Paulo 44, 85–90.
doi: 10.1590/S0036-46652002000200006
Edwards, C. N., Nicholson, G. D., Hassell, T. A., Everard, C. O., and Callender,
J. (1986). Thrombocytopenia in leptospirosis: the absence of evidence for
disseminated intravascular coagulation. Am. J. Trop. Med. Hyg. 35, 352–354.
Faine, S. (1999). Leptospira and Leptospirosis. Melbourne, VIC: MediSci.
Faine, S., Adler, B., Bolin, C., and Perolat, P. (1999). Leptospira and Leptospirosis.
2nd Edn. Melbourne, VIC: MediSci, 259.
Fernandes, L. G., de Morais, Z. M., Vasconcellos, S. A., and Nascimento,
A. L. (2015). Leptospira interrogans reduces fibrin clot formation by
modulating human thrombin activity via exosite I. Pathog. Dis. 73. 1–13.
doi: 10.1093/femspd/ftv001
Frick, I. M., Bjorck, L., and Herwald, H. (2007). The dual role of the
contact system in bacterial infectious disease. Thromb. Haemost. 98, 497–502.
doi: 10.1160/th07-01-0051
Goeijenbier, M., Gasem, M. H., Meijers, J. C., Hartskeerl, R. A., Ahmed, A.,
Goris, M. G., et al. (2015). Markers of endothelial cell activation and immune
activation are increased in patients with severe leptospirosis and associated with
disease severity. J. Infect. 71, 437–446. doi: 10.1016/j.jinf.2015.05.016
Haake, D. A. (2006). Hamster model of leptospirosis. Curr. Protoc. Microbiol
Chapter 12:Unit 12E.2. doi: 10.1002/9780471729259.mc12e02s02
Haake, D. A., Dundoo, M., Cader, R., Kubak, B. M., Hartskeerl, R. A., Sejvar, J. J.,
et al. (2002). Leptospirosis, water sports, and chemoprophylaxis. Clin. Infect.
Dis. 34, e40–e43. doi: 10.1086/339942
Hartman, E. G., van den Ingh, T. S., and Rothuizen, J. (1986). Clinical, pathological
and serological features of spontaneous canine leptospirosis. An evaluation of
the IgM- and IgG-specific ELISA. Vet. Immunol. Immunopathol. 13, 261–271.
doi: 10.1016/0165-2427(86)90078-4
Hartskeerl, R. A., Collares-Pereira, M., and Ellis, W. A. (2011). Emergence, control
and re-emerging leptospirosis: dynamics of infection in the changing world.
Clin. Microbiol. Infect. 17, 494–501. doi: 10.1111/j.1469-0691.2011.03474.x
Knights, S. F., and Ingram, G. I. (1967). Partial thromboplastin time test with
kaolin: diagnosis of haemophilia and Christmas disease without natural
reference plasmas. J. Clin. Pathol. 20, 616–619. doi: 10.1136/jcp.20.4.616
Ko, A. I., Goarant, C., and Picardeau, M. (2009). Leptospira: the dawn of the
molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol.
7, 736–747. doi: 10.1038/nrmicro2208
Levett, P. N. (2001). Leptospirosis. Clin. Microbiol. Rev. 14, 296–326.
doi: 10.1128/CMR.14.2.296-326.2001
Martinez-Lopez, D. G., Fahey, M., and Coburn, J. (2010). Responses of
human endothelial cells to pathogenic and non-pathogenic Leptospira
species. PLoS Negl. Trop. Dis. 4:e918. doi: 10.1371/journal.pntd.0
000918
Oehmcke, S., and Herwald, H. (2010). Contact system activation in severe
infectious diseases. J. Mol. Med. 88, 121–126. doi: 10.1007/s00109-009-0564-y
Pereira, M. M., Da Silva, J. J., Pinto, M. A., Da Silva, M. F., Machado, M. P., Lenzi,
H. L., et al. (2005). Experimental leptospirosis inmarmoset monkeys (Callithrix
jacchus): a new model for studies of severe pulmonary leptospirosis. Am. J.
Trop. Med. Hyg. 72, 13–20. doi: 10.4269/ajtmh.2005.72.13
Plank, R., and Dean, D. (2000). Overview of the epidemiology, microbiology,
and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2, 1265–1276.
doi: 10.1016/S1286-4579(00)01280-6
Qureshi, S. H., Yang, L., Manithody, C., and Rezaie, A. R. (2009). Membrane-
dependent interaction of factor Xa and prothrombin with factor Va in the
prothrombinase complex. Biochemistry 48, 5034–5041. doi: 10.1021/bi900240g
Rosing, J., Tans, G., Govers-Riemslag, J.W., Zwaal, R. F., andHemker, H. C. (1980).
The role of phospholipids and factor Va in the prothrombinase complex. J. Biol.
Chem. 255, 274–283.
Sitprija, V., Pipatanagul, V., Mertowidjojo, K., Boonpucknavig, V., and
Boonpucknavig, S. (1980). Pathogenesis of renal disease in leptospirosis: clinical
and experimental studies. Kidney Int. 17, 827–836. doi: 10.1038/ki.1980.95
Tapper, H., and Herwald, H. (2000). Modulation of hemostatic mechanisms in
bacterial infectious diseases. Blood 96, 2329–2337.
Vieira, M. L., Alvarez-Flores, M. P., Kirchgatter, K., Romero, E. C., Alves, I.
J., de Morais, Z. M., et al. (2013). Interaction of Leptospira interrogans with
human proteolytic systems enhances dissemination through endothelial cells
and protease levels. Infect. Immun. 81, 1764–1774. doi: 10.1128/IAI.00020-13
Vieira, M. L., andNascimento, A. L. (2016). Interaction of spirochetes with the host
fibrinolytic system and potential roles in pathogenesis. Crit. Rev. Microbiol. 42,
573–587. doi: 10.3109/1040841X.2014.972336
Vieira, M. L., deMorais, Z. M., Vasconcellos, S. A., Romero, E. C., and Nascimento,
A. L. (2011). In vitro evidence for immune evasion activity by human plasmin
associated to pathogenic Leptospira interrogans. Microb. Pathog. 51, 360–365.
doi: 10.1016/j.micpath.2011.06.008
Vieira, M. L., Naudin, C., Morgelin, M., Romero, E. C., Nascimento, A. L.,
and Herwald, H. (2016). Modulation of hemostatic and inflammatory
responses by Leptospira Spp. PLoS Negl. Trop. Dis. 10:e0004713.
doi: 10.1371/journal.pntd.0004713
Vieira, M. L., Vasconcellos, S. A., Goncales, A. P., de Morais, Z. M., and
Nascimento, A. L. (2009). Plasminogen acquisition and activation at the
surface of leptospira species lead to fibronectin degradation. Infect. Immun. 77,
4092–4101. doi: 10.1128/IAI.00353-09
Vinetz, J. M. (2001). Leptospirosis. Curr. Opin. Infect. Dis. 14, 527–538.
doi: 10.1097/00001432-200110000-00005
Wagenaar, J. F., Goris, M. G., Partiningrum, D. L., Isbandrio, B., Hartskeerl, R.
A., Brandjes, D. P., et al. (2010). Coagulation disorders in patients with severe
leptospirosis are associated with severe bleeding and mortality. Trop. Med. Int.
Health 15, 152–159. doi: 10.1111/j.1365-3156.2009.02434.x
Yang, H. L., Jiang, X. C., Zhang, X. Y., Li, W. J., Hu, B. Y., Zhao, G. P., et al.
(2006). Thrombocytopenia in the experimental leptospirosis of guinea pig is
not related to disseminated intravascular coagulation. BMC Infect. Dis. 6:19.
doi: 10.1186/1471-2334-6-19
Yang, L., Manithody, C., Qureshi, S. H., and Rezaie, A. R. (2008). Factor Va alters
the conformation of the Na+-binding loop of factor Xa in the prothrombinase
complex. Biochemistry 47, 5976–5985. doi: 10.1021/bi800319r
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer MVG and handling Editor declared their shared affiliation and
the handling Editor states that the process nevertheless met the standards of a fair
and objective review.
Copyright © 2017 Vieira, de Andrade, Morais, Vasconcellos, Dagli and Nascimento.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 10 March 2017 | Volume 8 | Article 500
